Artivion added to Conviction List at Needham

Needham added Artivion (AORT) to the firm’s Conviction List while maintaining a Buy rating and $58 price target Artivion is int he middle of a product cycle driven by its AMDS launch, which should be supplemented by the upcoming NEXUS launch, the analyst tells investors in a research note. The firm thinks Artivion can sustain low-teens or better organic revenue growth and 20% or better EBITDA growth.